All In Biotech

Drug Trial Radar · NCT05242471

A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 703 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

703

Actual

Start

Jul 22, 2022

Primary completion

May 23, 2025

Study completion Nov 5, 2029

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Feb 16, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.

Conditions

  • Crohn's Disease

Interventions

  • GuselkumabBiological

    Guselkumab will be administered as subcutaneous injection.

  • GolimumabBiological

    Golimumab will be administered as subcutaneous injection.

  • JNJ-78934804Biological

    JNJ-78934804 will be administered subcutaneously as per defined regimen.

  • PlaceboDrug

    Placebo will be administered as subcutaneous injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants with Clinical Remission at Week 48Time frame: Week 48
  2. Percentage of Participants with Endoscopic Response at Week 48Time frame: Week 48

Locations

456 sites in 36 countries. Site status is shown where the registry gives one.

  • University of Alabama Liver Center

    Birmingham, Alabama

  • Del Sol Research Management, LLC

    Tucson, Arizona

  • Moore Clinical Trials, LLC

    Little Rock, Arkansas

  • Om Research LLC

    Apple Valley, California

  • Valley Gastroenterology Medical Group

    Arcadia, California

  • Southern California Research Center

    Coronado, California

  • Desert Gastroenterology Associates

    Lancaster, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • UCLA

    Los Angeles, California

  • Hoag Memorial Hospital

    Newport Beach, California

  • UCI Irvine Medical Center

    Orange, California

  • Medical Associates Research Group, Inc.

    San Diego, California

  • University of California San Francisco

    San Francisco, California

  • University of Colorado

    Aurora, Colorado

  • Medical Research Center of Connecticut

    Hamden, Connecticut

  • Yale University School Of Medicine

    New Haven, Connecticut

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Pioneer Research Solutions Inc.

    Coconut Creek, Florida

  • Homestead Associates in Research Inc

    Homestead, Florida

  • Osceola Mental Health D/B/A Park Place Behavioral Health Care

    Kissimmee, Florida

  • Florida Research Center Inc.

    Lakewood Rch, Florida

  • University of Miami Hospital

    Miami, Florida

  • Gastroenterology Group Of Naples

    Naples, Florida

  • Omega Research Consultants

    Orlando, Florida

  • Synergy Clinical Research

    St. Petersburg, Florida

  • GCP Clinical Research

    Tampa, Florida

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia

  • University of Mississippi Medical Center

    Atlanta, Georgia

  • Gastroenterolgy Associates of Central GA

    Macon, Georgia

  • Gastrointestinal Specialists of Georgia

    Marietta, Georgia

  • Northwestern University

    Chicago, Illinois

  • IU Health University Hospital

    Indianapolis, Indiana

  • Gastroenterology of Southern Indiana

    New Albany, Indiana

  • Cotton O'Neil Digestive Health Center

    Topeka, Kansas

  • Ascension via Christi Research

    Wichita, Kansas

  • Univ. of KS School of Med

    Wichita, Kansas

  • Tri-State Gastroenterology Assoc

    Crestview Hills, Kentucky

  • University of Kentucky

    Lexington, Kentucky

  • Jewish Hospital

    Louisville, Kentucky

  • Gastroenterology Clinic of Acadiana

    Lafayette, Louisiana

Showing 40 of 456 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.